Alto Neuroscience, Inc. · NYSE:ANRO

K2 HealthVentures Equity Trust LLC reported a 5.60% stake in Alto Neuroscience, Inc. (Schedule 13G)

Event Jan 13, 2025 · Filed May 15, 2025

K2 HealthVentures Equity Trust LLC reported a 5.60% stake in Alto Neuroscience, Inc., 1,617,855 shares, as a passive investor on Jan 13, 2025. Filed May 15, 2025 (Schedule 13G).

Stake
5.60%
Shares
1,617,855
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
K2 HealthVentures Equity Trust LLC5.60%1,617,855
Parag Shah5.60%1,617,855
Anup Arora5.60%1,617,855

Source

View original at SEC

Related